Understanding BK Virus After Your Transplant
At a Glance
After a kidney transplant, anti-rejection medicines can allow dormant BK virus to become active. Regular urine and blood tests find changes early, allowing the transplant team to adjust medicines carefully to limit kidney injury while watching for rejection.
It is deeply frustrating to navigate a viral complication after you have already climbed the mountain of a kidney transplant. You have followed the protocols, taken the medications, and focused on recovery, only to be met with a new challenge called the BK polyomavirus (BKV). It is important to know that this is a common part of the transplant journey for many people, and finding it early is exactly why your team monitors you so closely [1][2].
What is the BK Virus?
The BK virus is a ubiquitous virus, meaning it is found almost everywhere. In fact, most people are exposed to it during childhood, often through a mild respiratory infection that passes without anyone noticing [3]. After that initial exposure, the virus doesn’t leave your body. Instead, it enters a state of latency—it “goes to sleep” in the urothelial and kidney tubular epithelial cells (the specific cells that make up the lining of your urinary tract and the filtering tubes of your kidneys) [4].
In a person with a typical immune system, the virus usually remains dormant. However, during periods of intense immunosuppression—such as the medications you must take to protect your new kidney—the virus is allowed to “wake up” and begin replicating [1]. This is not a failure on your part or your body’s part; it is a known complication of the delicate balance required to prevent organ rejection.
The Progression of BK Virus
BK virus reactivation often follows a pattern, though it is not inevitable and many patients clear the virus before it causes harm. Understanding the stages helps your doctors determine how to react.
- BK Viruria: This is when the virus is detected in your urine. It is very common, affecting 30% to 40% of kidney transplant recipients [3]. On its own, viruria (virus in the urine) does not usually mean the kidney is being damaged, but it is often the first “warning light” that the virus is active [5].
- BK Viremia (DNAemia): If the virus continues to multiply, it may spill over into your bloodstream. This is called viremia (virus in the blood). About 10% to 20% of recipients develop this [3]. Doctors watch these numbers closely because a high or rising viral load (the amount of virus in the blood) is a signal that the kidney may be at risk [6].
- BK Virus Nephropathy (BKVN): This is the most serious stage, occurring in about 1% to 10% of patients [3]. Nephropathy means the virus is actively causing physical injury to the kidney tissue.
How the Virus Affects the Kidney
While your kidney’s glomeruli filter your blood, the tubular epithelial cells process that filtered fluid. When the BK virus reactivates in the kidney, it targets these tubular cells. The virus “hijacks” these cells to create more copies of itself, which eventually causes the cells to die or malfunction [7].
As these cells are damaged, your immune system may respond by sending inflammatory cells to the area. This is called interstitial inflammation [8]. While your immune system is trying to help, this inflammation can contribute to tubular injury and, if left unchecked, can lead to scarring (fibrosis) that affects the kidney’s long-term function [7][9].
A Note on Contagion
Many patients wonder if they can pass the BK virus to their family members. Because BK is a reactivation of a virus already inside your body—and because nearly everyone in the general public has already been exposed to it—you do not need to take special isolation precautions in your home beyond your normal post-transplant hygiene.
A Delicate Balancing Act
Managing BK virus is often described as a “balancing act.” There are no standard antiviral drugs that effectively kill the BK virus without potentially harming the kidney [10]. Instead, the primary treatment is to carefully reduce your immunosuppression medications [11].
The goal is to lower the medication just enough so your own immune system can wake up and fight the virus, but not so much that your immune system begins to attack the transplanted kidney (rejection) [12]. Your care team will be monitoring your bloodwork frequently to find this “sweet spot” where the virus disappears and the kidney remains safe [1].
While this complication is serious and requires your full attention, it is manageable. Most patients who develop BK reactivation are able to clear the virus through these medication adjustments, especially when caught early through routine screening [1][6].
Common questions in this guide
What is BK virus after a kidney transplant?
Does finding BK virus in my urine mean my transplanted kidney is damaged?
What does a rising BK viral load mean?
How is BK virus nephropathy treated?
How will my transplant team monitor BK virus?
Can I spread BK virus to my family at home?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.What is my current plasma BK viral load, and how has it changed since my last test?
- 2.Has the virus caused physical damage to my kidney, or is it currently limited to my blood?
- 3.Which of my immunosuppression medications will we be adjusting first, and what is the target level we are aiming for?
- 4.How will we monitor for signs of organ rejection while we are lowering my medications to fight the virus?
- 5.What is the 'threshold' viral load for my specific case that would trigger a kidney biopsy?
- 6.How often will I need blood and urine tests during this balancing phase?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (12)
- 1
The Second International Consensus Guidelines on the Management of BK Polyomavirus in Kidney Transplantation.
Kotton CN, Kamar N, Wojciechowski D, et al.
Transplantation 2024; (108(9)):1834-1866 doi:10.1097/TP.0000000000004976.
PMID: 38605438 - 2
BK polyomavirus in solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice.
Hirsch HH, Randhawa PS,
Clinical transplantation 2019; (33(9)):e13528 doi:10.1111/ctr.13528.
PMID: 30859620 - 3
BK polyomavirus infection: more than 50 years and still a threat to kidney transplant recipients.
Parajuli S, Aziz F, Zhong W, Djamali A
Frontiers in transplantation 2024; (3()):1309927 doi:10.3389/frtra.2024.1309927.
PMID: 38993764 - 4
Non-permissive human conventional CD1c+ dendritic cells enable trans-infection of human primary renal tubular epithelial cells and protect BK polyomavirus from neutralization.
Sikorski M, Coulon F, Peltier C, et al.
PLoS pathogens 2021; (17(2)):e1009042 doi:10.1371/journal.ppat.1009042.
PMID: 33592065 - 5
High-level viruria as a screening tool for BK virus nephropathy in renal transplant recipients.
Chon WJ, Aggarwal N, Kocherginsky M, et al.
Kidney research and clinical practice 2016; (35(3)):176-81 doi:10.1016/j.krcp.2016.05.005.
PMID: 27668162 - 6
Incidence, risk factors, and outcome of BK polyomavirus infection after kidney transplantation.
Favi E, Puliatti C, Sivaprakasam R, et al.
World journal of clinical cases 2019; (7(3)):270-290 doi:10.12998/wjcc.v7.i3.270.
PMID: 30746369 - 7
Single-cell RNA-sequencing of BK polyomavirus replication in primary human renal proximal tubular epithelial cells identifies specific transcriptome signatures and a novel mitochondrial stress pattern.
Weissbach FH, Follonier OM, Schmid S, et al.
Journal of virology 2024; (98(12)):e0138224 doi:10.1128/jvi.01382-24.
PMID: 39513696 - 8
BK Virus Nephropathy: Histological Evolution by Sequential Pathology.
Nankivell BJ, Renthawa J, Sharma RN, et al.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2017; (17(8)):2065-2077 doi:10.1111/ajt.14292.
PMID: 28371308 - 9
Digital spatial profiling reveals the molecular signatures of BK virus infection in renal transplant recipients.
He L, Zhang Y, Dong K, et al.
Translational andrology and urology 2025; (14(7)):2089-2105 doi:10.21037/tau-2025-451.
PMID: 40800081 - 10
Comparing Urine and Blood Screening Methods to Detect BK Virus After Renal Transplant.
McGann K, DeWolfe D, Jacobs M, et al.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2021; (19(2)):104-109 doi:10.6002/ect.2019.0295.
PMID: 31801449 - 11
Ten tips on management of BK nephropathy in kidney transplant patients.
Geddes CC, Phelan PJ
Clinical kidney journal 2026; (19(4)):sfag061 doi:10.1093/ckj/sfag061.
PMID: 42111238 - 12
BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
Sharma R, Tzetzo S, Patel S, et al.
Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation 2016; (14(4)):377-84 doi:10.6002/ect.2016.0030.
PMID: 27267780
This page explains BK polyomavirus reactivation and BK virus nephropathy after kidney transplant for informational purposes only and does not constitute medical advice. Your transplant team should guide medication changes, testing, and decisions about biopsy or rejection monitoring.
Get notified when new evidence is published on BK-virus nephropathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.